Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.3K

Benefits of a comprehensive care model in patients with heart failure and anemia: UMIPIC program

José Manuel Cerqueiro González1, Álvaro González Franco2, Manuel Méndez Bailón3

  • 1Servicio de Medicina Interna, Hospital Universitario Lucus Augusti, Lugo, Spain.

Revista Clinica Espanola
|March 29, 2026
PubMed

Insights

The UMIPIC care program significantly reduced hospital admissions and overall mortality in heart failure (HF) patients with anemia over 12 months. This program shows a clear prognostic benefit for this vulnerable patient group.

Area of Science:

  • Cardiology and Internal Medicine
  • Clinical Research and Patient Outcomes

Background:

  • Heart failure (HF) and anemia are common comorbidities, negatively impacting patient prognosis.
  • Effective management strategies are crucial for improving outcomes in HF patients with anemia.

Purpose of the Study:

  • To assess the prognostic value of the UMIPIC care program for patients diagnosed with heart failure and anemia.
  • To compare clinical outcomes between patients receiving the UMIPIC program versus conventional care.

Main Methods:

  • Analysis of data from 3,152 patients with HF and anemia from the RICA registry.
  • Matched-pair analysis comparing a UMIPIC follow-up group (N: 621) with a conventional care group (N: 524).
  • Evaluation of hospital admissions and all-cause mortality over a 12-month follow-up period.

Main Results:

  • The UMIPIC group exhibited significantly lower HF admission rates (19.3% vs. 29.8%, p < 0.001).
  • Overall mortality was reduced in the UMIPIC group (24.8% vs. 36.6%, p < 0.001).
  • Patients with iron deficiency (ID) in the UMIPIC group also showed decreased HF admissions (19.1% vs. 32.5%, p < 0.001).

Conclusions:

  • The UMIPIC care program effectively lowers hospital admissions and overall mortality in HF patients with anemia within one year.
  • Further research is warranted to investigate the specific benefits of iron deficiency treatment within such integrated care programs.
Abstract

Keywords:
AnemiaDéficit de hierroHeart failureInsuficiencia cardiacaIron deficiencyPrograma UMIPICUMIPIC program

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
532
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
568
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
455
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
718
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757